Brief: Immuneering Reports Second Quarter 2022 Financial Results And Recent Business Highlights
10/08/2022 22:14
Aug 10 (Reuters) - Immuneering Corp IMRX.O :
* IMMUNEERING REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
* Q2 LOSS PER SHARE $0.44
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF
$128.1M IS
EXPECTED TO PROVIDE CASH RUNWAY INTO Q3 2024
* CONTINUES TO ANTICIPATE GENERATING APPROXIMATELY $250
MILLION OR
MORE IN TOPLINE REVENUE IN 2024
Source text for Eikon: ID:nGNXJNb16
Further company coverage: IMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immuneering
See all newsImmuneering expects cash runway to fund operations into 2029
Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend
U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT
U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners
U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences